Applied Clinical Trials Direct
Having trouble viewing this e-mail? Click here.
  November 12, 2013

In This Edition
News Roundup: EMA, FDA Provide Joint QbD Info
Blog Posts: Life Sciences On to the Cloud Computing
Marketplace: Marketplace


News Roundup
bullet EMA, FDA Provide Joint QbD Info
bullet DrugDev and CFS Clinical Discuss Investigator Solutions
bullet Certara Partners with Thomson Reuters for Data Access

Sponsored
Applied Clinical Trials launches new e-book, Risk-Based Monitoring for Clinical Trials
Download here.

Blogs Posts
bullet Life Sciences On to the Cloud Computing
bullet Cortellis Clinical Trials Intelligence Tool


Sponsored
Implementing a new approach to study design: what can I expect?
On-Demand Webcast
Register Free at www.appliedclinicaltrialsonline.com/studydesign

Events
bullet Risk-Based Monitoring: Myths, Models and Momentum

Sponsored
Applying Pharmacogenomics to enable real time decisions during drug development
On-Demand Webcast
Click here to Register Free.

Marketplace

Sponsored
BioClinica
Risk-Based Monitoring and Related Initiatives – A Data Management Professional’s Perspective. A FREE WEBINAR presented by industry expert Jonathan Andrus. Watch the Webinar NOW.


Sponsored
ACRP
ACRP Training Improves Performance – Courses Cover: Good Clinical Practice, Fundamentals, Project Management, Risk-Based Monitoring, Ethics, and More. 9 New Courses Coming January 2014! www.acrpnet.org/courses


Sponsored
Medidata(CTM Monitoring)
Case study: Read how DSP Clinical improved their CRA productivity by using Medidata CTMS to streamline their site monitoring operations. [Download Now]

Sponsored
BioClinica
Could you benefit from better Clinical Trials Supplies management?. Click Here for the Podcast and companion White Paper


Sponsored
Implementing Rare Disease Registries: Unique Challenges & Proactive Solutions
On Demand Webcast
To Register Free Click here.


Sponsored
Risk-based Monitoring Tools for Application
On Demand Webcast
To Register Free Click here.


Sponsored
Drug Development Strategies in China
Pharma and biotech firms who are relative newcomers to the Chinese market aren't aware that the regulatory climate has changed dramatically in recent years. SFDA approval times for Clinical Trials Approvals have dropped to 7-9 months for small molecules. There are also opportunities in China for sponsors that have not yet completed Phase II trials to create a parallel approval strategy. Even without final details (like final dosing) it’s possible to file a CTA for Phase III based on the most current early phase results. This parallel submission strategy can shave several months off the final approval time in China. Learn more.

Sponsored
IRT and EDC
The Unified Experience describes how sponsors and CROs can integrate and streamline complex processes spanning randomization, trial supply management and data collection for better clinical trials. Click here.


Sponsored
Editors’ Series: Monitoring Clinical Trials - Models, Myths and Momentum
Live Webcast: December 5, 2013 at 11:00 AM EST
Register free at www.appliedclinicaltrialsonline.com/Monitoring



CHINA REPORT
China is the third largest pharmaceutical market in the world and will become the second largest ahead of Japan by 2015. Everything you need to know to do business in the country; key economic sector data and exclusive interviews from regional leaders. Read more

Follow Us

Ask The Editor

Lisa Henderson
Editor in Chief
lhenderson@advanstar.com



CRO/Sponsor

Risk-Based Monitoring Conference SPOTLIGHT EVENT
Sponsor/CRO Systems & Business Process Integration
Nov. 13-14, 2013
Raleigh, NC

Download Brochure
Register

More in CRO/Sponsor